Both in Pharmaceuticals
Rocket Pharmaceuticals vs BioAge Labs
Over the past year RCKT returned −35.3% and BIOA returned −22.5%; their daily moves had a correlation of 0.27.
RCKT −35.3% BIOA −22.5%Growth of $1, one year, split-adjusted
| Metric | RCKT | BIOA |
|---|---|---|
| Price | $2.44 | $5.87 |
| Market cap | $267.9M | $269.4M |
| Today | −3.94% | −1.18% |
| 1 month | −5.8% | −13.8% |
| 6 months | −31.5% | −65.0% |
| Year to date | −30.5% | −55.6% |
| 1 year | −35.4% | −23.6% |
| Revenue growth (YoY) | — | +1.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −1064.7% |
| P/E (TTM) | — | — |
| Price / sales | — | 26.0× |
| Net cash | $262.5M | $318.7M |
| Dividend yield | — | — |
| Volatility (60d) | 66.4% | 67.7% |
| Short % of float | 19.2% | 12.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).